Global Breast Implants Market to accrue US $2260 Mn by 2024

September 24, 2019


As per the recent study published at MarketStudyReport.com under the title ‘Global Breast Implants Market Growth 2019-2024’, the worldwide breast implants market is anticipated to cross US $2260 million by the year.
 

Breast implantation is a medical procedure, wherein devices are implanted under the chest muscle, either to augment the breast size, or to reconstruct breast tissues after some damage or mastectomy. Breast implants are also applicable in revision surgeries when improvements are required after the original surgery. Increasing concern regarding body aesthetics and rising inclination towards cosmetic procedures will aid the expansion of breast implants market.
 

According to the research, the breast implants industry is bifurcated based on product type as saline and silicone. While considering the application spectrum, the market is divided as cosmetic surgery and reconstructive surgery.
 

The worldwide breast implants market was valued at US $1360 million in 2019 and is predicted to witness an annual growth rate of 8.9% over the forecast timeline. Moreover, the report also offers detailed insight about the trends, drivers, and challenges influencing the market outlook, along with the prevailing marketing strategies, customers and distribution channels.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1550611/
 

Speaking of the regional contribution, North America controlled the breast implants market with 48.22% consumption share in 2017, whereas Europe market held 19.83% share in the same year. Both the regions are expected to maintain this strong hold over the analysis period, owing to the presence of significant demand, claims the report.
 

The key contenders of the breast implants market profiled in the study include Establishment Labs, Allergan, Guangzhou Wanhe Plastic Materials, POLYTECH Health & Aesthetics, Hans Biomed, Mentor Worldwide, Sientra, Laboratories Arion, Groupe Sebbin, and GC Aesthetics. Among these, Allergan is the leading market player with 29.37% revenue share in 2017. These companies are undertaking strategic expansions and focusing on launching innovative products to enhance their market position.